In vitro cell cycle dynamics of primitive hematopoietic cells from human umbilical cord blood

References

• Nicola NA. Hematopoietic cell growth factors and their receptors. Annu Rev Biochem 1989; 58: 45–78.
   PubMed Web of Science ®Google Scholar
• Metcalf D. Hematopoietic cytokines. Blood 2008; 111: 485–491.
   PubMed Web of Science ®Google Scholar
• Dorshkind K. Regulation of hemopoiesis by bone marrow stromal cells and their products. Annu Rev Immunol 1990; 8: 111–138.
   PubMed Web of Science ®Google Scholar
• Greenberger JS. The hematopoietic microenvironment. Grit Rev Oncol Hematol 1991; 11: 65–84.
   PubMed Web of Science ®Google Scholar
• Mayani H, Guilbert Li, Janowska-Wieczorek A. Biology of the hemopoietic microenvironment. Eur J Haematol 1992; 49: 225–233.
   PubMed Web of Science ®Google Scholar
• Scadden DT. The stem cell niche as an entity of action. Nature 2006; 441: 1075–1079.
   PubMed Web of Science ®Google Scholar
• Silvennoinen O, Ihle JN. Signaling by the hematopoietic cytokine receptors. New York: Chapman & Hall, 1996; 219.
   Google Scholar
• Robb L. Cytokine receptors and hematopoietic differentiation. Oncogene 2007; 26: 6715–6723
   PubMed Web of Science ®Google Scholar
• Baker Si, Rane SG, Reddy EP. Hematopoietic cytokine receptor signaling. Oncogene 2007; 26: 6724–6737.
   PubMed Web of Science ®Google Scholar
• Zhang CC, Lodish HF. Cytokines regulating hematopoietic stem cell function. Curr Opin Hematol 2008; 15: 307–311.
   PubMed Web of Science ®Google Scholar
• Hartwell LH, Weinert TA. Checkpoints: controls that ensure the order of cell cycle events. Science 1989; 246: 629–634.
   PubMed Web of Science ®Google Scholar
• Israels ED, Israels LG. The cell cycle. Stem Cells 2001; 19: 88–91.
   PubMed Web of Science ®Google Scholar
• Quelle FW. Cytokine signaling to the cell cycle. Immunol Res 2007; 39: 173–184.
   PubMed Web of Science ®Google Scholar
• Matsushime H, Roussel M, Ashmun R, Sherr C. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 1991; 65: 701–713.
   PubMed Web of Science ®Google Scholar
• Sherr CJ. Growth factor-regulated G1 cyclins. Stem Cells 1994; 12: S47—S57.
   Web of Science ®Google Scholar
• Flores-Guzman P, Gutierrez-Rodriguez M, Mayani H. In vitro proliferation, expansion and differentiation of a CD34± cell-enriched hematopoietic cell population from human umbilical cord blood in response to recombinant cytokines. Arch Med Res 2003; 33: 107–114.
   Web of Science ®Google Scholar
• Flores-Guzman P, Flores-Figueroa E, Martinez-Jaramillo G, Mayani H. In vitro characterization of two lineage-negative CD34± cell-enriched hematopoietic cell populations from human UC blood. Cytotherapy 2005; 7: 334–344.
   PubMed Web of Science ®Google Scholar
• Flores-Guzman P, Martinez-Jaramillo G, Montesinos JJ, Valencia I, Mayani H. Growth kinetics of progenitor cell-enriched hematopoietic cell populations in long-term liquid cultures under continuous removal of mature cells. Cytotherapy 2006; 8: 299–307.
   PubMed Web of Science ®Google Scholar
• Wognum AW, Eaves EC, Thomas TE. Identification and isolation of hematopoietic stem cells. Arch Med Res 2003; 34: 461–475.
   PubMed Web of Science ®Google Scholar
• Alvarado-Moreno JA, Chavez-Gonzalez A, Cerbulo A, Arriaga L, Mayani H. Cell cycle differences in vitro between primitive hematopoietic cell populations from adult and umbilical cord blood. Stem Cells Dev 2007; 16: 223–229.
   PubMed Web of Science ®Google Scholar
• Koening JM, Luttge B, Benson NA, Christensen RD. Cell cycle status of CD34± cells in human fetal bone marrow. Early Human Dev 2001; 65: 159–163.
   PubMed Web of Science ®Google Scholar
• Uchida N, He D, Friera AM et al. The unexpected G0/G1 cell cycle status of mobilized hematopoietic stem cells from peripheral blood. Blood 1997; 89: 465–472.
   PubMed Web of Science ®Google Scholar
• Summers YJ, Heyworth CM, de Wynter EA et al. Cord blood Go CD34± cells have a thousand-fold higher capacity for generating progenitors in vitro than G1 CD34± cells. Stem Cells 2001; 19: 505–513.
   PubMed Web of Science ®Google Scholar
• Sanchez-Garcia J, Torres A, Herrera C, Alvarez MA. Cell cycle kinetic changes induced by interleukin-3 and interleukin-6 during ex vivo expansion of mobilized peripheral blood CD34 cells. Haematologica 2006; 91: 121–124.
   PubMed Web of Science ®Google Scholar
• Reddy GP, Tiarks CY, Pang L, Wuu J, Hsieh CC, Quesenberry Cell cycle analysis and synchronization of pluripotent hemato-poietic progenitor stem cells. Blood 1997; 90: 2293–2299.
   PubMed Web of Science ®Google Scholar
• Lemoli RM, Tafuri A, Fortuna A et al. Cycling status of CD34± cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factor. Blood 1997; 89: 1189–1196
   PubMed Web of Science ®Google Scholar
• Leibundgut K, Schmitz NM, Hirt A. Catalytic activities of G1 cyclin-dependent kinases and phosphorylation of retinoblastoma protein in mobilized peripheral blood CD34± hematopoietic progenitor cells. Stem Cells 2005; 23: 1002–1011.
   PubMed Web of Science ®Google Scholar
• Traycoff CM, Abboud MR, Laver J, Clapp W, Srour EF. Rapid exit from G0/G1 phases of the cell cycle in response to stem cell factor confers on umbilical cord blood CD34± cells an enhanced ex vivo expansion potential. Exp Hematol 1994; 22: 1264–1272.
   PubMed Web of Science ®Google Scholar
• Janzen V, Forkert A, Fleming HE et al. Stem-cell ageing modified by the cyclin-dependent kinase inhibitor pl6INK4a. Nature 2006; 443: 421–426.
   PubMed Web of Science ®Google Scholar
• Cheng M, Olivier P, Diehl JA et al. The p21 (Cipl) and p27 (Kipl) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J 1999; 18: 1571–1583.
   PubMed Web of Science ®Google Scholar
• Yaroslavskiy B, Watkins S, Donnenberg AD, Patton Ti, Steinman RA. Subcellular and cell-cycle expression profiles of CDK-inhibitors in normal differentiating myeloid cells. Blood 1999; 93: 2907–2917.
   PubMed Web of Science ®Google Scholar
• Marone M, Pierelli L, Mozzetti S et al. High cyclin-dependent kinase inhibitors in Bc1-2 and Bc1-xL-expressing CD34± prolifer-ating haematopoietic progenitors. Br J Haematol 2000; 110: 654–662.
   PubMed Web of Science ®Google Scholar
• Lansdorp PM, Dragowska W, Mayani H. Ontogeny-related changes in proliferative potential of human hematopoietic cells. J Exp Med 1993; 178: 787–791.
   PubMed Web of Science ®Google Scholar
• Gilmore GL, DePasquale DK, Lister J, Shaduck RK. Ex vivo expansion of human umbilical cord blood and peripheral blood CD34± hematopoietic stem cells. Exp Hematol 2000; 28: 1297–1305.
   PubMed Web of Science ®Google Scholar
• Tanavde VM, Malehorn MT, Lumkul R et al. Human stem-progenitor cells from neonatal cord blood have greater hemato-poietic expansion capacity than those from mobilized adult blood. Exp Hematol 2002; 30: 816–823.
   PubMed Web of Science ®Google Scholar
• Mayani H, Lansdorp PM. Biology of human umbilical cord blood-derived hematopoietic stem/progenitor cells. Stem Cells 1998; 16: 153–165.
   PubMed Web of Science ®Google Scholar
• Broxmeyer HE. Proliferative, self-renewal and survival character-istics of cord blood hematopoietic stem and progenitor cells. In: Broxmeyer HE. (ed) Cord blood: biology, immunology, banking, and clinical transplantation. Bethesda, MD: AABB Press, 2004; 1–21.
   Google Scholar